Indications
ELIQUIS (apixaban) is a prescription
medicine used in adults to reduce the risk of stroke and blood clots in people who have atrial fibrillation (AFib), a type of irregular heartbeat, not caused by a heart valve problem.
ELIQUIS (apixaban) is a prescription
medicine used in adults to treat blood clots in the veins of your legs (deep vein thrombosis-DVT) or lungs (pulmonary embolism-PE), and to reduce the risk of them occurring again after receiving treatment for blood clots.
ELIQUIS (apixaban) is a prescription
medicine used in children from birth and older to treat blood clots in the veins of legs and lungs (venous thromboembolism) after at least 5 days of initial anticoagulant treatment, and to reduce the risk of them happening again. ELIQUIS was not studied and is not recommended in children weighing less than 5.7 pounds (2.6 kg).
ELIQUIS (apixaban) is a prescription
medicine used in adults to help prevent a blood clot in the veins of your legs (deep vein thrombosis-DVT) and lungs (pulmonary embolism-PE) of people who have just had hip or knee replacement surgery.
Indications
ELIQUIS (apixaban) is a
prescription medicine used in adults to reduce the risk of stroke and blood clots in people who have atrial fibrillation (AFib), a type of irregular heartbeat, not caused by a heart valve problem.
ELIQUIS (apixaban) is a
prescription medicine used in adults to treat blood clots in the veins of your legs (deep vein thrombosis-DVT) or lungs (pulmonary embolism-PE), and to reduce the risk of them occurring again after receiving treatment for blood clots.
ELIQUIS (apixaban) is
a prescription medicine used in children from birth and older to treat blood clots in the veins of legs and lungs (venous thromboembolism) after at least 5 days of initial anticoagulant treatment, and to reduce the risk of them happening again. ELIQUIS was not studied and is not recommended in children weighing less than 5.7 pounds (2.6 kg).
ELIQUIS (apixaban) is a
prescription medicine used in adults to help prevent a blood clot in the veins of your legs (deep vein thrombosis-DVT) and lungs (pulmonary embolism-PE) of people who have just had hip or knee replacement surgery.
Savings Resources
Learn about the Free Trial Offer and how eligible patients can potentially save on out-of-pocket costs with the ELIQUIS Co-pay Card.
About DVT/PE
Learn how a deep vein thrombosis (DVT) blood clot can lead to a pulmonary embolism (PE), and the role of ELIQUIS to treat DVT/PE and reduce the risk of them happening again.
About ELIQUIS
Find out more about ELIQUIS, including clinical study results, possible side effects, and additional factors for you and your healthcare professional to consider.
Make the most of your doctor appointments
Tips from a nurse to prepare you for talking with your healthcare professional.
CAROL—
Acute Care Nurse Practitioner
Carol was compensated for her
time and expenses.